{"id":46785,"date":"2022-08-01T14:01:50","date_gmt":"2022-08-01T12:01:50","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/new-cryo-plasma-focused-ion-beam-to-streamline-cellular-cryo-electron-tomography-research\/"},"modified":"2022-08-01T14:01:50","modified_gmt":"2022-08-01T12:01:50","slug":"new-cryo-plasma-focused-ion-beam-to-streamline-cellular-cryo-electron-tomography-research","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/new-cryo-plasma-focused-ion-beam-to-streamline-cellular-cryo-electron-tomography-research\/","title":{"rendered":"New Cryo-Plasma Focused Ion Beam to Streamline Cellular Cryo-Electron Tomography Research"},"content":{"rendered":"
\n

\nThermo Scientific Arctis Cryo-Plasma FIB enables speed and consistency of cellular cryo-electron tomography<\/i>\n<\/p>\n

HILLSBORO, Ore.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Thermo Scientific Arctis Cryo-Plasma Focused Ion Beam (Cryo-PFIB), a new connected and automated microscope designed to advance the pace of cryo-electron tomography (cryo-ET) research.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nCryo-ET makes it possible to study how proteins and other molecules operate together in a cellular context, at resolutions unsurpassed by other microscopy techniques, and has enormous potential for cell biology research, including the study of infectious disease, neurodegenerative disease, and other globally impactful structural biology applications. However, the process of preparing optimal samples for cryo-ET is still time-consuming and complex.\n<\/p>\n

\nThe Arctis Cryo-PFIB helps users address these challenges with advanced automation and new connectivity capabilities within the workflow, significantly increasing throughput compared to other commercially available solutions for fast, reproducible production of samples for cryo-ET.\n<\/p>\n

\n\u201cOur goal is to provide an end-to-end cryo-ET workflow for new and experienced users,\u201d said Trisha Rice, vice president and general manager of life sciences at Thermo Fisher. \u201cBy expanding our automation capabilities to our cryo-PFIB portfolio, we can pave the way for cryo-ET to become a frontier technique for cell biology.\u201d\n<\/p>\n

\nThe system is designed to provide high-quality samples with consistent thickness while minimizing sample contamination risks. Users will benefit from integrated correlative microscopy, dedicated Plasma FIB technology, advanced automation and new connectivity capabilities, including simplified sample loading and transfer. Highlights include:\n<\/p>\n